首页> 美国卫生研究院文献>other >Direct Deposition of Gas Phase Generated Aerosol Gold Nanoparticles into Biological Fluids - Corona Formation and Particle Size Shifts
【2h】

Direct Deposition of Gas Phase Generated Aerosol Gold Nanoparticles into Biological Fluids - Corona Formation and Particle Size Shifts

机译:将气相生成的气溶胶金纳米颗粒直接沉积到生物流体中-电晕形成和粒度变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An ongoing discussion whether traditional toxicological methods are sufficient to evaluate the risks associated with nanoparticle inhalation has led to the emergence of Air-Liquid interface toxicology. As a step in this process, this study explores the evolution of particle characteristics as they move from the airborne state into physiological solution. Airborne gold nanoparticles (AuNP) are generated using an evaporation-condensation technique. Spherical and agglomerate AuNPs are deposited into physiological solutions of increasing biological complexity. The AuNP size is characterized in air as mobility diameter and in liquid as hydrodynamic diameter. AuNP:Protein aggregation in physiological solutions is determined using dynamic light scattering, particle tracking analysis, and UV absorption spectroscopy. AuNPs deposited into homocysteine buffer form large gold-aggregates. Spherical AuNPs deposited in solutions of albumin were trapped at the Air-Liquid interface but was readily suspended in the solutions with a size close to that of the airborne particles, indicating that AuNP:Protein complex formation is promoted. Deposition into serum and lung fluid resulted in larger complexes, reflecting the formation of a more complex protein corona. UV absorption spectroscopy indicated no further aggregation of the AuNPs after deposition in solution. The corona of the deposited AuNPs shows differences compared to AuNPs generated in suspension. Deposition of AuNPs from the aerosol phase into biological fluids offers a method to study the protein corona formed, upon inhalation and deposition in the lungs in a more realistic way compared to particle liquid suspensions. This is important since the protein corona together with key particle properties (e.g. size, shape and surface reactivity) to a large extent may determine the nanoparticle effects and possible translocation to other organs.
机译:正在进行的有关传统毒理学方法是否足以评估与纳米颗粒吸入​​有关的风险的讨论导致了气液界面毒理学的出现。作为此过程的一个步骤,本研究探索了粒子特征从空气传播到生理溶液的演变。机载金纳米粒子(AuNP)是使用蒸发冷凝技术生成的。球形和团聚的AuNP被沉积到生物复杂性日益增加的生理溶液中。 AuNP的尺寸以空气为迁移率直径,以液体为流体动力学直径为特征。 AuNP:蛋白质在生理溶液中的聚集是使用动态光散射,颗粒跟踪分析和紫外线吸收光谱法确定的。沉积到同型半胱氨酸缓冲液中的AuNPs形成大的金聚集体。沉积在白蛋白溶液中的球形AuNP被截留在气液界面处,但很容易悬浮在溶液中,大小接近于空气中的颗粒,表明AuNP:蛋白质复合物的形成得以促进。沉积到血清和肺液中会产生更大的复合物,反映出更复杂的蛋白质电晕的形成。紫外吸收光谱表明在溶液中沉积后,AuNPs没有进一步聚集。与悬浮液中产生的AuNPs相比,沉积的AuNPs的电晕显示出差异。与颗粒液体悬浮液相比,将AuNPs从气溶胶相沉积到生物流体中提供了一种方法,用于研究在肺部吸入和沉积后形成的蛋白质电晕,该方法更现实。这是重要的,因为蛋白质电晕与关键的粒子特性(例如大小,形状和表面反应性)在很大程度上可以决定纳米粒子的作用以及可能转移到其他器官。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号